While StockTwits is rarely any better than iHub, Y
Post# of 148287
(Total Views: 818)
Posted On: 11/05/2023 12:39:49 PM
While StockTwits is rarely any better than iHub, Yahoo, etc. someone has been posting all of the docs from Pacer of the Suzanne Strayhorn interview. Quite eye-opening to behold the level of f***ery and bias she engaged in.
I take some solace in that it appears she left the FDA in 2022. So hopefully someone else was assigned to Cytodyn since then and has a far better understanding of Leronlimab. At minimum, I hope whoever that person is doesn't do their "research" on iHub like Strayhorn did. Unreal.
I take some solace in that it appears she left the FDA in 2022. So hopefully someone else was assigned to Cytodyn since then and has a far better understanding of Leronlimab. At minimum, I hope whoever that person is doesn't do their "research" on iHub like Strayhorn did. Unreal.
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼